We chatted to the VP of Ecosystem, Operations and Strategy of the PharmaLedger Association, Clarisse Dias da Mota, about the progress that’s been made since the PharmaLedger...
We chatted to the VP of Ecosystem, Operations and Strategy of the PharmaLedger Association, Clarisse Dias da Mota, about the progress that’s been made since the PharmaLedger...
The IHI Forum 2026 was held in Brussels, Belgium on 20-21 October.
An interactive session that introduced you to practical tools and resources to help you share data with confidence when working in collaborative consortia.
If you want to invest your own resources in IHI projects via in-kind or cash contributions, this page will tell you how.
Discover how in-kind contributions from industry are key to the success of our projects, allowing them to deliver results that would not be possible via other funding models.
IHI held a workshop in 2025 examining project outcomes, challenges and opportunities regarding neurodegenerative diseases in Europe.
EDENT1FI and INNODIA have taken part in the development of a set of recommendations for policymakers.
Niklas Blomberg, IHI’s executive director, exchanged views with Members of the European Parliament from the SANT committee about how public-private partnerships like IHI can propel...
VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.